It is an exciting time to be involved in the cell and gene therapy industries. There are both opportunities and challenges around analytical testing, manufacturing, process automation, supply chain, regulations and business deals to name but a few, often still with more questions than answers.
Informa Connect Life Sciences conducted one of the biggest surveys of its kind across cell and gene therapy professionals from pharma, biotechs, academia, CDMOs, service providers and regulators around the world. This final report based on 165 responses reveals unique insights into the state of the cell and gene therapy industries in 2018; the hottest potential opportunities; the biggest challenges and how industry insiders are tackling them.
The report also features an introduction by Dan Stanton, editor of BioProcess Insider, exploring what some of the key takeaways mean for the industry.
To download simply log in or register for an Informa Connect account, which will give you access to all our exclusive premium content.
有任何问题或有兴趣赞助砰的一声吗ure content? Email andrew.burrows@informa.com.
Fast track cell, gene & car-t commercialization from concept to robust patient-centric delivery.
Log in or create an Informa Connect account to access this content
Creating an account also means you'll get special access to article updates and exclusive industry content.